CANTI, GIANFRANCO
CANTI, GIANFRANCO
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells
2018 A. Calastretti, G. Gatti, V. Lucini, S. Dugnani, G. Canti, F. Scaglione, A. Bevilacqua
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells
2017 G. Gatti, V. Lucini, S. Dugnani, A. Calastretti, G. Spadoni, A. Bedini, S. Rivara, M. Mor, G. Canti, F. Scaglione, A. Bevilacqua
Fluorescence molecular tomography of an animal model using structured light rotating view acquisition
2013 N. Ducros, A. Bassi, G. Valentini, G. Canti, S. Arridge, C. D'Andrea
Fluorescence molecular tomography on animal model by means of multiple views structured light illumination
2013 N. Ducros, A. Bassi, G. Valentini, G. Canti, S. Arridge, C. D'Andrea
Computational modeling of the metabolic states regulated by the kinase Akt
2012 E. Mosca, R. Alfieri, C. Maj, A. Bevilacqua, G. Canti, L. Milanesi
Systems biology of the metabolic network regulated by the Akt pathway
2012 E. Mosca, M. Barcella, R. Alfieri, A. Bevilacqua, G. Canti, L. Milanesi
Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia
2010 G. Canti, A.L. Calastretti, A.T. Bevilacqua, E. Reddi, G. Palumbo, A.N. Nicolin
Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy
2010 C. Compagnin, M. Mognato, L. Celotti, G. Canti, G. Palumbo, E. Reddi
B cell lymphoma (Bcl)-2 protein is the major determinant in bcl-2 adenine-uridine-rich element turnover overcoming HuR activity
2009 L. Ghisolfi, A. Calastretti, S. Franzi, G. Canti, M. Donnini, S. Capaccioli, A. Nicolin, A. Bevilacqua
Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles
2007 P. Bruno, A. Calastretti, M. Priulla, L. Asnaghi, F. Scarlatti, A. Nicolin, G. Canti
Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase
2007 M. Priulla, A. Calastretti, P. Bruno, A. Azzariti, A. Paradiso, G. Canti, A. Nicolin
Stabilization of cellular mRNAs and up-regulation of proteins by oligoribonucleotides homologous to the Bcl2 adenine-uridine rich element motif
2007 A. Bevilacqua, L. Ghisolfi, S. Franzi, G. Maresca, R. Gherzi, S. Capaccioli, A. Nicolin, G. Canti
Low doses of cisplatin or gemcitabine plus photofrin/photodynamic therapy : disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299)
2006 E. Crescenzi, A. Chiaviello, G. Canti, E. Reddi, B.M. Veneziani, G. Palumbo
Terapia fotodinamica e nuovi fotosensibilizzanti
2005 G. Canti, L.A. Calastretti
Increased bcl2 expression by antisense oligoribonucleotides targeting the adenine-uridine-rich element motif
2005 L. Ghisolfi, A. Nicolin, L. Papucci, A. Bevilacqua, G. Canti, G. Tataranni, A. Lapucci, N. Schiavone, S. Capaccioli
Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells
2004 S. Banfi, E. Caruso, S. Capriolo, L. Mazzagatti, G. Canti, R. Ravizza, M. Gariboldi, E. Monti
Antitumor activity of photodynamic therapy, adoptive immunotherapy, and chemotherapy in experimental tumor
2004 G. Canti, A. Calastretti, R. Cubeddu, P. Tironi, G. Valentini, E. Reddi, G. Palumbo
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt
2004 L. Asnaghi, A.L. Calastretti, A.T. Bevilacqua, I. D’Agnano, G. Gatti, G. Canti, S. Capaccioli, A.N. Nicolin
Fotoimmunologia. In Fotodermatologia
2003 G. Canti, A. De Simone, A. Calastretti
Bcl-2 protein is required for the adenine/uridine-rich element (ARE)-dependent degradation of its own messenger
2003 A. Bevilacqua, M.C. Ceriani, G. Canti, L. Asnaghi, R. Gherzi, G. Brewer, L. Papucci, N. Schiavone, S. Capaccioli, A. Nicolin